Finance
![[Left-Right] Travis Seet, CFO, and Dr Chin Pak Lin, CEO, Asian Healthcare Specialists; Lim Wai Mun, CEO and founder, and Edwin Basuki, CFO, Doctor Anywhere Credit: Doctor Anywhere](/sites/mhn/files/styles/230x130/public/2025-07/Photo_Doctor%2520Anywhere%2520acquires%2520Singapore-listed%2520Asian%2520Healthcare%2520Specialists%252C%2520secures%2520additional%2520US%252438.8%2520million%2520funding.jpg?itok=BMyCZa_X)
The company seeks to meet the rising demand for specialised care across Southeast Asia.
Some experts assert the legislation is preemptive and may stifle innovation, while others argue it has the potential to improve patient access to meaningful healthcare.
The companies first partnered in 2020 to develop a prescription digital therapeutic for schizophrenia. They said a treatment strategy for the condition "would benefit from a multi-product approach."
Click Therapeutics received FDA Breakthrough Device Designation for a prescription digital therapeutic for episodic migraine, and Superior HealthPlan announced a home care partnership with MedArrive and Brave Health.
The deal is expected to close in January 2023.
According to TechCrunch and Fierce Healthcare, the health data company also recently closed a $200 million structured equity infusion.
The companies also raised $13 million in funding to support the merger.
Though funding has fallen this year, Dr. Sunny Kumar, partner at GSR Ventures, said there are still opportunities for startups that can prove their value.
The company said it needed to restructure following "a period of rapid growth and hiring."
Medical waste-management firm Stericycle sold the business to Carenet for approximately $45 million in cash.